Page last updated: 2024-08-21

vancomycin and Pneumonia, Staphylococcal

vancomycin has been researched along with Pneumonia, Staphylococcal in 151 studies

Research

Studies (151)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (3.97)	18.7374
1990's	10 (6.62)	18.2507
2000's	48 (31.79)	29.6817
2010's	76 (50.33)	24.3611
2020's	11 (7.28)	2.80

Authors

Authors	Studies
Araki, N; Izumikawa, K; Kakeya, H; Kamihira, S; Kihara, R; Kohno, S; Morinaga, Y; Nakamura, S; Seki, M; Tsukamoto, K; Yamamoto, Y; Yanagihara, K	1
Laohavaleeson, S; Nicolau, DP; Tessier, PR	1
Choi, CM; Choi, MG; Kim, HC; Lee, JH; Park, HJ	1
Carr, AL; Hayes, J; Lopez-Ruiz, A; Louzon, PR; Marinucci, V; Sniffen, J	1
Liu, X; Tian, Z; Wang, M	1
Ingraham, NE; Kalinoski, M	1
Hasegawa, Y; Ishida, T; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Mukae, H; Niki, Y; Shindo, Y; Soma, K; Tateda, K; Tomono, K; Watanabe, A; Yamamoto, Y; Yanagihara, K	1
Bai, H; Duan, J; Li, Z; Liu, Y; Lu, C; Mu, H; Xiao, Y; Zhang, X; Zou, S	1
Parker, D; Peignier, A; Planet, PJ	1
Donnelly, HK; Paonessa, J; Pickens, CI; Postelnick, M; Qi, C; Wunderink, RG	1
DeMott, JM; Peksa, GD; Renzoni, AJ	1
Finnigan, A; Lita, E; Liu, C; Newcomb, AB; Stodghill, J; Teicher, E	1
Dupont, J; Prat, D; Sztrymf, B	1
Corman, S; Gordon, LM; Leung, GH; Lodise, TP; McKinnell, JA; Patel, D	1
Alarcon Velasco, SV; Mbaebie, NC; Touhey, J	1
Ackerman, KG; Bubeck Wardenburg, J; Cvijanovich, N; Gedeit, RG; Giuliano, JS; Hall, MW; Hartman, ME; Markovitz, B; Moffitt, KL; Newhams, MM; Novak, T; Randolph, AG; Sanders, RC; Shein, SL; Tarquinio, KM; Thomas, NJ; Truemper, EJ; Weiss, SL; Xu, R	1
Bruss, J; Dwyer, J; Jacobs, M; Lacy, MK; Nogid, B	1
Kiselinova, M; Piers, R; Van Den Noortgate, N; Velghe, A; Verhasselt, B	1
Abdelraouf, K; Kidd, JM; Nicolau, DP	1
Donnelly, HK; Lizza, BD; Malczynski, M; Paonessa, JR; Pickens, CI; Qi, C; Shah, RD; Wunderink, RG	1
Akizawa, K; Fukumoto, T; Kaku, N; Kimura, H; Konno, S; Morinaga, Y; Nagaoka, K; Suzuki, M; Yamashita, Y; Yanagihara, K	1
Bansal, S; Bauer, C; Sun, K; Verma, AK; Yajjala, VK	1
Abgueguen, P; Boutoille, D; Caillon, J; Crochette, N; Huon, JF; Moal, F; Navas, D; Orain, J; Potel, G	1
Afasizheva, A; Badiou, C; Chambers, HF; Diep, BA; Kajikawa, O; Le, HN; Lina, G; Matute-Bello, G; Sellman, B; Tkaczyk, C	1
Barreto, JN; Huang, DB; Morrow, LE; Puzniak, LA	1
Chavanet, P	1
Cheng, L; Cheng, LI; Damschroder, M; Datta, V; Du, Q; Feng, H; Hilliard, JJ; Hua, L; Keller, A; O'Day, T; Ren, S; Robbie, G; Sellman, BR; Shi, Y; Stover, CK; Suzich, J; Tkaczyk, C; Yu, X; Zinsou, R	1
Muscedere, J	1
Blasi, F; Chastre, J; Masterton, RG; Rello, J; Torres, A; Welte, T	1
Altare, F; Asehnoune, K; Broquet, A; Caillon, J; Davieau, M; Jacqueline, C; Potel, G; Roquilly, A	1
Caffrey, AR; LaPlante, KL; Morrill, HJ; Puzniak, LA	1
Barriere, SL; Corey, GR; Genter, FC; Rubinstein, E; Stryjewski, ME	1
Charbonneau, C; Chastre, J; Gao, X; Nathwani, D; Niederman, M; Patel, DA; Shorr, AF; Simor, A; Stephens, JM	1
Chastre, J; Gao, X; Haider, S; Li, JZ; Myers, DE; Niederman, MS; Solem, CT; Stephens, JM; Wan, Y	1
Chen, C; Fan, H; Huang, Y; Peng, F; Tong, Y; Yuan, S	1
Stahlmann, R	1
Altman, DR; Holzman, RS; Kafer, JM; Mendes, RE; Rose, HR; Shopsin, B; Smyth, DS; Torres, VJ; Wasserman, GA; Wible, M	1
Li, JQ; Li, Y; Liu, R; Luo, ZX; Zhamg, H; Zhang, DW; Zhang, GL; Zhang, SY	1
Bihorac, A; Davis, R; Efron, P; Findlay, R; Lanz, J; Leclaire, A; Lemon, S; Marker, P; Moore, F; Ozrazgat-Baslanti, T; Tommolino, K; Vaught, A; Voils, S	1
Chung, DR; Huh, K	1
Peyrani, P; Ramirez, J	1
Cohen, TS; Datta, V; Hilliard, JJ; Hua, L; Sellman, BR; Shi, Y; Stover, CK; Suzich, J; Tkaczyk, C	1
Biswas, P; Niederman, MS; Puzniak, LA; Shorr, AF	1
Collins, CD; Schwemm, AK	1
Caffrey, AR; LaPlante, KL; Morrill, HJ; Noh, E	1
Ghebremedhin, B; Rasche, K; Yayan, J	1
Jeon, YL; Kang, SY; Kim, MH; Lee, WI; Yang, HS	1
Charbonneau, C; Chastre, J; De Salas-Cansado, M; Gao, X; Mesa, F; Nieto, M; Rello, J; Solé-Violán, J; Solem, CT; Wan, Y	1
Bosso, JA; Tong, MC; Wisniewski, CS; Wolf, B	1
Bin, C; Rello, J	1
da Costa, C; Equils, O; Lipsky, BA; Wible, M	1
Abu Ghanimeh, M; Abu Omar, M; Gohar, A; Tylski, E	1
Manaloor, JJ; Patel, PR; Scheffer, AL	1
Hifumi, T; Inoue, J; Kanemura, T; Kato, H; Kiriu, N; Koido, Y; Nishimoto, N; Okada, I; Takada, H; Yoshioka, H	1
Bishara, J; Cohen, J; Eliakim-Raz, N; Fisher, S; Hellerman, M; Margalit, I; Shaked, H; Yahav, D; Zusman, O	1
Baby, N; Faust, AC; Goodman, EL; Knoll, L; Sheperd, LA; Smith, T	1
Chaimanee, P; Kosalaraksa, P; Lumbiganon, P; Surakunprapha, P	1
Izumikawa, K; Kakeya, H; Kamihira, S; Kohno, S; Kurihara, S; Morinaga, Y; Nakamura, S; Ohnishi, Y; Seki, M; Yamada, Y; Yamamoto, Y; Yanagihara, K	1
Dickson, RP; Martinez, SM; Ortiz, JR	1
Füzi, M; Gacs, M; Kispál, G; Molnár, K; Pászti, J; Szeberin, Z; Tóth, A; Ungvári, E; Violka, M	1
Baker, T; De Cock, E; Duttagupta, S; Hardewig, J; Krueger, WA; Müller, E; Piecyk, A; Reisinger, E; Resch, A; Sorensen, S	1
Aston, JL; Creech, CB; Dortch, MJ; Dossett, LA; May, AK	1
Niederman, MS	1
Erstad, BL; Kopp, BJ; Nix, DE; Norris, CJ; Patanwala, AE	1
Schlaudecker, JD	1
Florescu, MC; Hanson, M; Hermsen, ED; Rupp, ME; Sankaranarayanan, J; Stoner, JA	1
Mazer, MA; Ramsey, KM	1
Choi, IS; Chung, JW; Han, SY; Ho Choi, S; Hong, SB; Jung, YJ; Kim, MN; Kim, NJ; Kim, WD; Koh, Y; Lim, CM; Yun, SC	1
Boyeras Navarro, ID; Luna, CM	1
Aquino, VR; de Souza Martins, D; dos Santos, RP; Goldani, LZ; Machado, DP; Nagel, F; Nazário, R	1
Hsueh, PR; Lai, CC; Lin, SH; Tan, CK	1
Aoyama, T; Hayashi, H; Iida, H; Matsumoto, Y; Shimazaki, N; Umeda, K	1
Aruj, P; Bruno, D; Luna, CM	1
Bertuccio, T; Bongiorno, D; Borbone, S; Cafiso, V; Campanile, F; Nicolosi, D; Perez, M; Purrello, S; Scuderi, C; Stefani, S	1
Barriere, SL; Corey, GR; Fagon, JY; Friedland, HD; Genter, FC; Kanafani, ZA; Kitt, MM; Kollef, MH; Lalani, T; Lee, PC; Lentnek, AL; Luna, CM; Nannini, EC; Niederman, MS; Rahav, G; Rocha, MG; Rubinstein, E; Shorr, AF; Stryjewski, ME; Torres, A	1
Choi, EY; Choi, SH; Hong, SB; Huh, JW; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lim, CM	1
Akase, T; Imaura, M; Kobayashi, K; Kohata, Y; Takahashi, H; Yamada, Y; Yokoyama, H	1
Akinnusi, ME; El-Solh, AA; Gao, W; Hattemer, A	1
Karabekos, D; Karvouniaris, M; Makris, D; Zakynthinos, E	1
Kalil, AC	1
Betageri, G; Muppidi, K; Pumerantz, AS; Wang, J	1
Agusti, C; de la Bellacasa, JP; Esperatti, M; Filella, X; Guerrero, L; Li Bassi, G; Liapikou, M; Luque, N; Marco, F; Martinez-Olondris, P; Quera, MA; Rigol, M; Soy, D; Torres, A	1
Lipman, J; Roberts, JA; Udy, AA	1
Cho, EM; Chung, J; Hong, SB; Jang, HJ; Koh, YS; Lim, CM; Oh, JM	1
Kollef, MH	2
Crandon, JL; Hagihara, M; Keel, RA; Nicolau, DP; Tessier, PR	1
Bosch, A; Calvo, M; Esperatti, M; Fernández-Barat, L; Ferrer, M; Gabarrús, A; Li Bassi, G; Luque, N; Martínez-Olondris, P; Rigol, M; Torres, A; Vila, J	1
Docobo-Pérez, F; Domínguez-Herrera, J; Ibáñez-Martínez, J; Jiménez-Mejias, ME; López-Rojas, R; Pachón, J; Pichardo, C	1
Agustí, C; Cortadellas, N; Esperatti, M; Fernández-Barat, L; Ferrer, M; Guerrero, L; Li Bassi, G; Luque, N; Martínez-Olondris, P; Rigol, M; Saucedo, LM; Sierra, JM; Soy, D; Torres, A; Vila, J	1
Pumerantz, AS	1
Alaniz, C; Pogue, JM	1
Deshpande, LM; Farrell, DJ; Jones, RN; Mendes, RE; Shopsin, B; Smyth, DS	1
Hashimoto, K; Kozuki, H; Ohkusu, K; Otera, H; Tada, K; Yamamoto, G	1
Abdelghany, O; Ruggero, MA; Topal, JE	1
Huang, YC; Lai, JY; Lee, WJ; Lien, R; Lim, WH	1
Church, TJ; Segarra-Newnham, M	1
Allen, J; Brevard, SB; Frotan, MA; Gonzalez, RP; Rostas, J; Simmons, JD	1
Nathwani, D; Tillotson, GS	1
Andrivet, P; Gauthier, JM; Lefort, C; Lesueur, A	1
DIAMOND, EF	1
Barth, AL; Kuplich, N; Lutz, L; Machado, A	1
Bauer, TT	1
Cammarata, SK; Croos-Dabrera, RV; Kollef, MH; Rello, J; Wunderink, RG	1
Kollef, MH; Shorr, AF; Susla, GM	1
Ioanas, M; Lode, H	1
Lin, D; Powers, JH; Ross, DB; Soreth, J	1
Matsuyama, K; Nishikata, M; Okamoto, K; Uchida, T; Yasuda, N; Yoshida, M	1
Diaz, E; Garnacho-Montero, J; Muñoz, E; Olona, M; Rello, J; Sa-Borges, M; Sirgo, G; Sole-Violan, J	1
Blot, S	1
Arns, Cda C; Follador, W; Guerra, A; Machado, AR	1
Stevens, DL	1
Fukuhara, S; Ishii, Y; Maeda, Y; Murakami, T; Ohta, M; Omoda, K	1
Noskin, GA; Postelnick, MJ; Scheetz, MH; Wunderink, RG	1
Bertha, G; Grisold, A; Krause, R; Laferl, H; Smolle, KH; Szell, M; Wenisch, C	1
Baltopoulos, G; Dimopoulos, G; Koulenti, D; Myrianthefs, P	1
Koulenti, D; Rello, J	1
Higashiyama, Y; Hirakata, Y; Izumikawa, K; Kohno, S; Miyazaki, Y; Mizuta, Y; Seki, M; Tomono, K; Tsukamoto, K; Yanagihara, K	1
Daniel Mullins, C; Kuznik, A; Levine, AR; Liu, LZ; Obeidat, NA; Shaya, FT; Wong, W	1
Mallol, J; Rello, J	1
Doherty, JA; Isakow, W; Jeffres, MN; Kollef, MH; McKinnon, PS; Micek, ST; Ritchie, DJ	1
Liu, C; McCalla, S; Minkoff, H; Rotas, M	1
Vanni, T	1
Hall, RG; Maclayton, DO	1
Pea, F; Viale, P	1
Marik, PE; Salerno, D; Vahid, B	1
Estes, L; Orenstein, R	1
Lyles, A	1
Estes, L; Orenstem, R	1
Doherty, JA; Isakow, W; Jeffres, MN; Kollef, MH; Micek, ST	1
Adams-Huet, B; Hall, RG	1
Paterson, DL; Potoski, BA	1
Bédos, JP; Moine, P	1
Abughali, N; Hall, GS; Kumar, D; Kumar, ML; Tuohy, M; Yee-Guardino, S	1
Ferraris, R; Nahum, M; Pesce, L; Poloniato, G	1
Campelli, A; Di Noto, C; Fabbri, A; Ferraris, R; Mantero, E; Nahum, M	1
Kishimoto, T	1
Maezawa, H; Nakazawa, Y; Saito, A; Sakai, O; Sakamoto, M; Shiba, K; Shindou, N; Yoshida, M; Yoshikawa, K	1
Shimada, K	1
Johnston, BL	1
Arakawa, M; Honma, T; Hoshino, S; Miyao, H; Sato, S; Sega, H; Shimazu, Y; Tsukada, H; Wada, K; Yoshikawa, H	1
Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H	1
Hanaki, H; Hiramatsu, K; Inaba, Y; Kuwahara-Arai, K; Labischinski, H; Sasaki, K	1
Kohno, S; Tomono, K; Yamamoto, Y	1
Cheeseman, SH; Daly, JS; Gerstadt, K; Mitchell, M; Wessolossky, M	1
Anholm, JD; Cheadle, WG; Fabian, TC; Fagon, J; Falcone, RE; Gibert, C; Haas, DW; Lilienthal, F; Paganin, F; Patrick, H; Torres, A	1
Bhavnani, SM; Birmingham, MC; Forrest, A; Moise, PA; Schentag, JJ	1
Blazevic, D; Laverdiere, M; Sabath, LD; Wheeler, N; Wilkinson, BJ	1
Emmerson, AM; Garau, J	1
Mason, AD; McManus, AT; McManus, WF; Pruitt, BA	1
Esposito, AL; Kephart, PA	1

Reviews

18 review(s) available for vancomycin and Pneumonia, Staphylococcal

Article	Year
A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methic Tropical medicine & international health : TM & IH, 2023, Volume: 28, Issue:4 Topics: Adult; Anti-Bacterial Agents; Creatinine; Cross Infection; Healthcare-Associated Pneumonia; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin	2023
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20 Suppl 4 Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Risk Factors; Vancomycin	2014
[Antibiotics for treatment of infections by methicillin-resistant Staphylococcus aureus (MRSA)]. Pneumologie (Stuttgart, Germany), 2014, Volume: 68, Issue:10 Topics: Acetamides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Evidence-Based Medicine; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin	2014
Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia. Expert review of anti-infective therapy, 2015, Volume: 13, Issue:2 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Drug Resistance, Bacterial; Early Diagnosis; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pandemics; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Vancomycin	2015
What is the best therapeutic approach to methicillin-resistant Staphylococcus aureus pneumonia? Current opinion in infectious diseases, 2015, Volume: 28, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin	2015
Case 2: Shoulder Pain in 7-year-old Girl. Pediatrics in review, 2016, Volume: 37, Issue:11 Topics: Bacteremia; Child; Combined Modality Therapy; Community-Acquired Infections; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Risk Assessment; Shoulder Pain; Thoracic Surgery, Video-Assisted; Treatment Outcome; Vancomycin	2016
Treatment options for nosocomial pneumonia due to MRSA. The Journal of infection, 2009, Volume: 59 Suppl 1 Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin	2009
Management of methicillin-resistant Staphylococcus aureus pneumonia. Current opinion in infectious diseases, 2010, Volume: 23, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Community-Acquired Infections; Cross Infection; Humans; Incidence; Infusions, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin	2010
Nosocomial MRSA pneumonia: data from recent clinical trials. Reviews on recent clinical trials, 2011, Volume: 6, Issue:3 Topics: Acetamides; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross Infection; DNA, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vancomycin	2011
PEGylated liposomal vancomycin: a glimmer of hope for improving treatment outcomes in MRSA pneumonia. Recent patents on anti-infective drug discovery, 2012, Dec-01, Volume: 7, Issue:3 Topics: Animals; Humans; Liposomes; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Polyethylene Glycols; Treatment Outcome; Vancomycin	2012
Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:12 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin	2012
The role of vancomycin in the treatment paradigm. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Jan-01, Volume: 42 Suppl 1 Topics: Anti-Bacterial Agents; Bacteremia; Drug Therapy, Combination; Endocarditis, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Failure; Vancomycin	2006
Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:12 Topics: Cross Infection; Drug Resistance, Bacterial; Equipment Contamination; Humans; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Staphylococcus aureus; Streptococcus pneumoniae; Treatment Failure; Vancomycin; Ventilators, Mechanical; Virulence	2005
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia. Pharmacotherapy, 2006, Volume: 26, Issue:4 Topics: Anti-Bacterial Agents; Humans; Lung; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Treatment Outcome; Vancomycin	2006
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care. Expert opinion on pharmacotherapy, 2006, Volume: 7, Issue:12 Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin	2006
Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; MEDLINE; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2007
Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia--a critical review. Seminars in respiratory infections, 1994, Volume: 9, Issue:3 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	1994
[Staphylococcal pneumonia]. Ryoikibetsu shokogun shirizu, 1999, Issue:23 Pt 1 Topics: Anti-Bacterial Agents; Diagnosis, Differential; Drug Resistance, Microbial; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	1999

Trials

16 trial(s) available for vancomycin and Pneumonia, Staphylococcal

Article	Year
Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial. Chest, 2019, Volume: 155, Issue:5 Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteriological Techniques; Bronchoalveolar Lavage Fluid; Diagnostic Tests, Routine; Drug Resistance, Microbial; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pilot Projects; Pneumonia, Staphylococcal; Reproducibility of Results; Vancomycin	2019
Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clinical therapeutics, 2013, Volume: 35, Issue:10 Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Body Weight; Cross Infection; Dose-Response Relationship, Drug; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Treatment Outcome; Vancomycin	2013
The ZEPHyR study: a randomized comparison of linezolid and vancomycin for MRSA pneumonia. Medecine et maladies infectieuses, 2013, Volume: 43, Issue:11-12 Topics: Acetamides; Adult; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Kidney Diseases; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin	2013
Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies. BMC infectious diseases, 2014, Apr-04, Volume: 14 Topics: Aged; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Humans; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Treatment Outcome; Vancomycin	2014
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Critical care (London, England), 2014, Jul-22, Volume: 18, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Vancomycin	2014
Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid. Clinical therapeutics, 2014, Sep-01, Volume: 36, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Drug Costs; Female; Health Resources; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Renal Dialysis; Renal Insufficiency; Treatment Outcome; Vancomycin	2014
Cytotoxic Virulence Predicts Mortality in Nosocomial Pneumonia Due to Methicillin-Resistant Staphylococcus aureus. The Journal of infectious diseases, 2015, Jun-15, Volume: 211, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Toxins; Cell Line; Cell Survival; Cross Infection; Culture Media; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neutrophils; Pneumonia, Staphylococcal; Vancomycin; Virulence; Virulence Factors; Young Adult	2015
Predictors of Clinical Success in the Treatment of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Nosocomial Pneumonia (NP). PloS one, 2015, Volume: 10, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Vancomycin	2015
Linezolid Versus Vancomycin in the Empiric Treatment of Nosocomial Pneumonia: A Cost-Utility Analysis Incorporating Results from the ZEPHyR Trial. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2015, Volume: 18, Issue:5 Topics: Anti-Bacterial Agents; Computer Simulation; Cost Savings; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Drug Costs; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Monte Carlo Method; Pneumonia, Staphylococcal; Probability; Prospective Studies; Quality-Adjusted Life Years; Treatment Outcome; Uncertainty; Vancomycin	2015
The effect of diabetes mellitus on outcomes of patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: data from a prospective double-blind clinical trial comparing treatment with linezolid versus vancomycin. BMC infectious diseases, 2016, 09-06, Volume: 16 Topics: Adult; Aged; Anti-Bacterial Agents; Diabetes Mellitus; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Prospective Studies; Retrospective Studies; Treatment Outcome; Vancomycin	2016
Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. Critical care medicine, 2010, Volume: 38, Issue:1 Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Critical Care; Cross Infection; Drug Therapy, Combination; Female; Follow-Up Studies; Hospital Mortality; Humans; Intensive Care Units; Korea; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Probability; Prospective Studies; Rifampin; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Vancomycin	2010
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Jan-01, Volume: 52, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Female; Humans; Lipoglycopeptides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin	2011
Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia. Journal of clinical microbiology, 2012, Volume: 50, Issue:11 Topics: Acetamides; Anti-Bacterial Agents; Cluster Analysis; Cross Infection; DNA, Bacterial; Double-Blind Method; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Oxazolidinones; Pneumonia, Staphylococcal; Prospective Studies; Staphylococcal Protein A; United States; Vancomycin	2012
Evaluation of clinical efficacy of Maeda's nomogram for vancomycin dosage adjustment in adult Japanese MRSA pneumonia patients. Drug metabolism and pharmacokinetics, 2006, Volume: 21, Issue:1 Topics: Adult; Aged; Algorithms; Anti-Bacterial Agents; Creatinine; Female; Humans; Japan; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin	2006
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection]. The Japanese journal of antibiotics, 1997, Volume: 50, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin	1997
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. American journal of respiratory and critical care medicine, 2000, Volume: 161, Issue:3 Pt 1 Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Prospective Studies; Treatment Outcome; Vancomycin; Virginiamycin	2000

Other Studies

117 other study(ies) available for vancomycin and Pneumonia, Staphylococcal

Article	Year
Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Bronchopneumonia; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Humans; Lung; Male; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Specific Pathogen-Free Organisms; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vancomycin Resistance	2008
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus	2008
Comparison of mortality and clinical failure rates between vancomycin and teicoplanin in patients with methicillin-resistant Staphylococcus aureus pneumonia. BMC infectious diseases, 2022, Jul-07, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Teicoplanin; Vancomycin	2022
Pharmacist-Driven Methicillin-Resistant The Annals of pharmacotherapy, 2023, Volume: 57, Issue:5 Topics: Adult; Anti-Bacterial Agents; Critical Illness; Humans; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Pharmacists; Pneumonia, Staphylococcal; Polymerase Chain Reaction; Retrospective Studies; Staphylococcal Infections; Vancomycin	2023
Ventilator-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia in a Patient with a Negative MRSA Nasal Swab. The American journal of case reports, 2023, Oct-14, Volume: 24 Topics: Anti-Bacterial Agents; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcal Infections; Vancomycin; Ventilators, Mechanical	2023
Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Cross Infection; Drug Monitoring; Female; Humans; Japan; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Prognosis; Prospective Studies; Risk Factors; Teicoplanin; Treatment Outcome; Vancomycin	2020
Hyaluronic acid-coated ZIF-8 for the treatment of pneumonia caused by methicillin-resistant Staphylococcus aureus. International journal of biological macromolecules, 2020, Jul-15, Volume: 155 Topics: Animals; Anti-Bacterial Agents; Drug Carriers; Female; Hyaluronic Acid; Methicillin-Resistant Staphylococcus aureus; Mice; Nanoparticles; Pneumonia, Staphylococcal; RAW 264.7 Cells; Vancomycin; Zeolites	2020
Differential Induction of Type I and III Interferons by Infection and immunity, 2020, 09-18, Volume: 88, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Proteins; Cells, Cultured; Cytokines; Drug Resistance, Bacterial; Interferon Type I; Lysostaphin; Mice; Microbial Sensitivity Tests; Mutation; Pneumonia, Staphylococcal; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virulence	2020
Association between a rapid diagnostic test to detect methicillin-resistant Infection control and hospital epidemiology, 2021, Volume: 42, Issue:11 Topics: Anti-Bacterial Agents; Diagnostic Tests, Routine; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcal Infections; Vancomycin	2021
Emergency department methicillin-resistant Staphylococcus aureus nare screen effect on pneumonia treatment duration. The American journal of emergency medicine, 2021, Volume: 44 Topics: Adult; Aged; Anti-Bacterial Agents; Emergency Service, Hospital; Female; Hospitalization; Humans; Linezolid; Male; Mass Screening; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nasal Cavity; Pneumonia, Staphylococcal; Retrospective Studies; Time Factors; Vancomycin	2021
Predictive Value of the Methicillin-Resistant Surgical infections, 2021, Volume: 22, Issue:9 Topics: Adult; Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcal Infections; Vancomycin	2021
Linezolid versus vancomycin in Methicillin Resistant Staphylococcus aureus nosocomial pneumonia in the elderly. The American journal of emergency medicine, 2017, Volume: 35, Issue:8 Topics: Acetamides; Aged; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin	2017
Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus. Clinical therapeutics, 2018, Volume: 40, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Stewardship; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2018
Common variable immunodeficiency presenting in a man with recurrent pneumonia caused by BMJ case reports, 2018, Mar-20, Volume: 2018 Topics: Age of Onset; Aged; Anti-Bacterial Agents; Common Variable Immunodeficiency; Drug Resistance, Bacterial; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Lung; Male; Pneumonia, Staphylococcal; Recurrence; Staphylococcus lugdunensis; Vancomycin	2018
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant Staphylococcus aureus Coinfection in Children With Influenza-related Critical Illness. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 01-18, Volume: 68, Issue:3 Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Coinfection; Critical Illness; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Prospective Studies; Survival Analysis; Treatment Outcome; Vancomycin	2019
Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials. Pharmacotherapy, 2018, Volume: 38, Issue:10 Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Creatinine; Female; Healthcare-Associated Pneumonia; Humans; Kidney Function Tests; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Vancomycin	2018
Methicillin-resistant Acta clinica Belgica, 2019, Volume: 74, Issue:6 Topics: Aged, 80 and over; Anti-Bacterial Agents; Blood Culture; Cross Infection; Diagnosis, Differential; Fatal Outcome; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Needs Assessment; Nursing Homes; Patient Selection; Pneumonia, Staphylococcal; Prognosis; Risk Factors; Time-to-Treatment; Vancomycin	2019
Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia. The Journal of antimicrobial chemotherapy, 2019, 04-01, Volume: 74, Issue:4 Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Female; Linezolid; Lung; Mice, Inbred BALB C; Neutropenia; Oxazolidinones; Pneumonia, Staphylococcal; Protein Synthesis Inhibitors; Tetrazoles; Treatment Outcome; Vancomycin	2019
Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9 Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Toxins; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Healthcare-Associated Pneumonia; Hemolysin Proteins; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Pneumonia, Staphylococcal; Vancomycin; Virulence Factors	2019
Linezolid Attenuates Lethal Lung Damage during Postinfluenza Methicillin-Resistant Staphylococcus aureus Pneumonia. Infection and immunity, 2019, Volume: 87, Issue:10 Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Female; Gene Expression; Gentamicins; Hemolysin Proteins; L-Lactate Dehydrogenase; Linezolid; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Orthomyxoviridae Infections; Plasmids; Pneumonia, Staphylococcal; Survival Analysis; Vancomycin	2019
Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia. Medecine et maladies infectieuses, 2020, Volume: 50, Issue:3 Topics: Aged; Costs and Cost Analysis; Cross Infection; Diagnosis-Related Groups; Drug Costs; Economics, Nursing; Female; France; Hospitalization; Hospitals, Urban; Humans; Infusions, Intravenous; Length of Stay; Linezolid; Male; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Vancomycin	2020
Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. The Journal of infectious diseases, 2013, Volume: 208, Issue:1 Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Bacterial Toxins; Chemokine CCL2; Disease Models, Animal; Exotoxins; Hemolysin Proteins; Interleukin-8; Leukocidins; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Rabbits; Vancomycin	2013
Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Acetamides; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Bacterial Toxins; Bronchoalveolar Lavage Fluid; Chemokines; Drug Synergism; Drug Therapy, Combination; Female; Hemolysin Proteins; Immunization, Passive; Kidney; Linezolid; Lung; Mice; Mice, Inbred C57BL; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Survival Analysis; Vancomycin	2014
Which antibiotic for hospital acquired pneumonia caused by MRSA? BMJ (Clinical research ed.), 2014, Feb-13, Volume: 348 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin	2014
Linezolid dampens neutrophil-mediated inflammation in methicillin-resistant Staphylococcus aureus-induced pneumonia and protects the lung of associated damages. The Journal of infectious diseases, 2014, Sep-01, Volume: 210, Issue:5 Topics: Acetamides; Animals; Anti-Bacterial Agents; Antigens, Ly; Bacterial Load; Cytokines; Disease Models, Animal; Endothelial Cells; Immunologic Factors; Injections, Subcutaneous; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Neutrophils; Oxazolidinones; Peroxidase; Pneumonia, Staphylococcal; Vancomycin	2014
Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia. Clinical therapeutics, 2014, Apr-01, Volume: 36, Issue:4 Topics: Aged; Anti-Bacterial Agents; Case-Control Studies; Female; Hospitalization; Humans; Intensive Care Units; Linezolid; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Odds Ratio; Pneumonia, Staphylococcal; Treatment Outcome; United States; Vancomycin; Veterans	2014
Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia. BioMed research international, 2014, Volume: 2014 Topics: Animals; Anti-Bacterial Agents; Blood Cell Count; Female; Humans; Lung; Lysostaphin; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Pneumonia, Staphylococcal; Recombinant Proteins; Vancomycin	2014
[Analysis of serum vancomycin concentration after administration of different doses in children with Staphylococcus aureus pneumonia]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2014, Volume: 16, Issue:10 Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Pneumonia, Staphylococcal; Vancomycin	2014
Gram stain can be used to safely discontinue vancomycin therapy for early pneumonia in the trauma intensive care unit. The American surgeon, 2014, Volume: 80, Issue:12 Topics: Adult; Cohort Studies; Critical Care; Female; Gentian Violet; Glasgow Coma Scale; Humans; Injury Severity Score; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Safety; Phenazines; Pneumonia, Staphylococcal; Retrospective Studies; Sensitivity and Specificity; Trauma Centers; Vancomycin; Withholding Treatment; Wounds and Injuries; Young Adult	2014
MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Broadly Neutralizing Antibodies; Female; Immunocompromised Host; Linezolid; Lung; Mice; Mice, Inbred C57BL; Pneumonia, Staphylococcal; Staphylococcus aureus; Survival Rate; Vancomycin	2015
Vancomycin Dosing Considerations in a Real-World Cohort of Obese and Extremely Obese Patients. Pharmacotherapy, 2015, Volume: 35, Issue:9 Topics: Aged; Anti-Bacterial Agents; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Obesity; Obesity, Morbid; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin	2015
No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period. PloS one, 2015, Volume: 10, Issue:9 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Disease Outbreaks; Female; Humans; Kaplan-Meier Estimate; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Survival Rate; Vancomycin	2015
Optimum initial loading dose of vancomycin for pneumonia caused by methicillin-resistant Staphylococcus aureus. The Journal of infection, 2016, Volume: 72, Issue:1 Topics: Anti-Bacterial Agents; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2016
Nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus treated with linezolid or vancomycin: A secondary economic analysis of resource use from a Spanish perspective. Medicina intensiva, 2016, Volume: 40, Issue:8 Topics: Anti-Bacterial Agents; Cross Infection; Double-Blind Method; Health Care Costs; Humans; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin	2016
Comparison of Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Pneumonia: Institutional Implications. Pharmacotherapy, 2016, Volume: 36, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Health Care Costs; Hospitalization; Humans; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin	2016
Cost of nosocomial pneumonia: the example of vancomycin versus linezolid-shorter stay or fewer complications? International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 51 Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Hospitalization; Humans; Length of Stay; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Quality of Life; Renal Insufficiency; Vancomycin	2016
Congenital pulmonary airway malformation (CPAM) with initial presentation in an adult: a rare presentation of a rare disease. BMJ case reports, 2016, Sep-26, Volume: 2016 Topics: Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoscopy; Clindamycin; Cystic Adenomatoid Malformation of Lung, Congenital; Drug Substitution; Humans; Lung; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Rare Diseases; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin	2016
Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly. The American journal of emergency medicine, 2017, Volume: 35, Issue:2 Topics: Aged; Analysis of Variance; Anti-Bacterial Agents; Body Mass Index; Comorbidity; Cross Infection; Female; Hospital Mortality; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Organ Dysfunction Scores; Outcome Assessment, Health Care; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin	2017
Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2017
Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Nose; Pneumonia, Staphylococcal; Polymerase Chain Reaction; Retrospective Studies; Time Factors; Vancomycin	2017
Post operative penicillin-non-susceptible Streptococcus pneumoniae meningitis and septic shock in a child. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2008, Volume: 91, Issue:4 Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Drug Resistance, Bacterial; Female; Humans; Infant; Lincomycin; Meningoencephalitis; Pneumonia, Staphylococcal; Postoperative Complications; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	2008
Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection. International journal of antimicrobial agents, 2008, Volume: 32, Issue:5 Topics: Animals; Anti-Bacterial Agents; Blood-Borne Pathogens; Carbapenems; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Pneumonia, Staphylococcal; Staphylococcus aureus; Tissue Distribution; Vancomycin; Vancomycin Resistance	2008
A case of rapidly progressive necrotizing pneumonia caused by community-acquired methicillin-resistant Staphylococcus aureus. Respiratory care, 2008, Volume: 53, Issue:9 Topics: Anti-Bacterial Agents; Combined Modality Therapy; Community-Acquired Infections; Fatal Outcome; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Pneumonia, Staphylococcal; Respiration, Artificial; Vancomycin	2008
First report of heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) causing fatal infection in Hungary. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:5 Topics: Anti-Bacterial Agents; Cardiac Surgical Procedures; Catheter-Related Infections; Drug Resistance, Neoplasm; Fatal Outcome; Humans; Hungary; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Postoperative Complications; Vancomycin	2008
Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany. Infection, 2009, Volume: 37, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Drug Costs; Female; Germany; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Models, Economic; Oxazolidinones; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin	2009
Risk factors for treatment failure in patients receiving vancomycin for hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia. Surgical infections, 2010, Volume: 11, Issue:1 Topics: Aged; Animals; Anti-Bacterial Agents; Critical Care; Cross Infection; Drug Utilization; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Treatment Failure; Vancomycin	2010
Vancomycin dosing for pneumonia in critically ill trauma patients. The Journal of trauma, 2009, Volume: 67, Issue:4 Topics: Adult; Anti-Bacterial Agents; Comorbidity; Critical Illness; Cross Infection; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Vancomycin; Wounds and Injuries	2009
A refractory case of community-acquired pneumonia. The Journal of family practice, 2009, Volume: 58, Issue:11 Topics: Acetamides; Adult; Anti-Bacterial Agents; Asthma; Community-Acquired Infections; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Emergency Service, Hospital; Female; Follow-Up Studies; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Oxygen Inhalation Therapy; Pneumonia, Staphylococcal; Radiography, Thoracic; Recurrence; Risk Assessment; Sputum; Staphylococcal Infections; Treatment Outcome; Vancomycin	2009
Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Expert opinion on drug safety, 2010, Volume: 9, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Creatinine; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Female; Humans; Kidney Diseases; Length of Stay; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Osteomyelitis; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin	2010
Addition of rifampin to vancomycin for the treatment of pneumonias due to methicillin-resistant Staphylococcus aureus: caveat emptor. Critical care medicine, 2010, Volume: 38, Issue:1 Topics: Critical Care; Cross Infection; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Prognosis; Rifampin; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin	2010
Vancomycin minimal inhibitory concentration from broth microdilution and Etest in respiratory tract samples of patients with ventilation-associated pneumonia. The Journal of hospital infection, 2010, Volume: 76, Issue:2 Topics: Adult; Anti-Bacterial Agents; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiratory System; Vancomycin	2010
Vancomycin plus rifampicin for methicillin-resistant Staphylococcus aureus pneumonia benefits only those who have no development of rifampicin resistance during treatment. Critical care medicine, 2010, Volume: 38, Issue:8 Topics: Critical Care; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Rifampin; Risk Assessment; Treatment Outcome; Vancomycin	2010
Clinical factors affecting the efficacy of vancomycin in methicillin-resistant Staphylococcus aureus pneumonia. International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Neoplasms; Parenteral Nutrition; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin	2010
Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really? Critical care medicine, 2010, Volume: 38, Issue:9 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Infections; Vancomycin	2010
Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates. International journal of antimicrobial agents, 2010, Volume: 36, Issue:5 Topics: Anti-Bacterial Agents; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcal Skin Infections; Vancomycin; Vancomycin Resistance	2010
Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive care medicine, 2011, Volume: 37, Issue:4 Topics: Aged; Anti-Bacterial Agents; APACHE; Cohort Studies; Cross Infection; Dose-Response Relationship, Drug; Female; Humans; Male; Medical Audit; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Republic of Korea; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2011
[Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2011, Volume: 131, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Economics, Pharmaceutical; Female; Health Care Costs; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Patient Care Team; Pharmacists; Pneumonia, Staphylococcal; Retrospective Studies; Vancomycin	2011
Does linezolid modulate lung innate immunity in a murine model of methicillin-resistant Staphylococcus aureus pneumonia? Critical care medicine, 2011, Volume: 39, Issue:8 Topics: Acetamides; Analysis of Variance; Animals; Anti-Infective Agents; Apoptosis; Confidence Intervals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Female; Immunity, Innate; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutrophils; Oxazolidinones; Peroxidase; Pneumonia, Staphylococcal; Random Allocation; Survival Rate; Treatment Outcome; Vancomycin	2011
Linezolid does not show advantages over vancomycin in modulating the pulmonary immune response: how should we conciliate these new findings with the Zephyr trial results? Critical care medicine, 2011, Volume: 39, Issue:8 Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; Immunity, Innate; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Risk Assessment; Treatment Outcome; Vancomycin	2011
PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Animals; Anti-Bacterial Agents; Kidney; Liposomes; Lung; Macrophages; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Polyethylene Glycols; Tissue Distribution; Vancomycin	2011
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs. Critical care medicine, 2012, Volume: 40, Issue:1 Topics: Acetamides; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Interleukin-6; Interleukin-8; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiration, Artificial; Swine; Tumor Necrosis Factor-alpha; Vancomycin	2012
Do we understand the impact of altered physiology, consequent interventions and resultant clinical scenarios in the intensive care unit? The antibiotic story. Anaesthesia and intensive care, 2011, Volume: 39, Issue:6 Topics: Anti-Bacterial Agents; Body Fluid Compartments; Cardiac Output; Cardiac Surgical Procedures; Critical Illness; Female; Fluid Therapy; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Monitoring, Intraoperative; Pneumonia, Staphylococcal; Sepsis; Thermodilution; Vancomycin	2011
Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients. Anaesthesia and intensive care, 2011, Volume: 39, Issue:6 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; APACHE; Area Under Curve; Cohort Studies; Critical Care; Critical Illness; Dose-Response Relationship, Drug; Female; Half-Life; Humans; Kidney; Kidney Function Tests; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Prospective Studies; Treatment Failure; Treatment Outcome; Vancomycin; Young Adult	2011
Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly. Critical care medicine, 2012, Volume: 40, Issue:1 Topics: Acetamides; Animals; Anti-Bacterial Agents; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin	2012
Comparative in vivo efficacies of epithelial lining fluid exposures of tedizolid, linezolid, and vancomycin for methicillin-resistant Staphylococcus aureus in a mouse pneumonia model. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Acetamides; Administration, Oral; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Pneumonia, Staphylococcal; Survival Rate; Tetrazoles; Vancomycin	2012
Direct analysis of bacterial viability in endotracheal tube biofilm from a pig model of methicillin-resistant Staphylococcus aureus pneumonia following antimicrobial therapy. FEMS immunology and medical microbiology, 2012, Volume: 65, Issue:2 Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Equipment and Supplies; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Viability; Microscopy, Confocal; Oxazolidinones; Placebos; Pneumonia, Staphylococcal; Spain; Staining and Labeling; Swine; Vancomycin	2012
Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:8 Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Load; Disease Models, Animal; Female; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Oxazolidinones; Pneumonia, Staphylococcal; Treatment Outcome; Vancomycin	2012
Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes. Critical care medicine, 2012, Volume: 40, Issue:8 Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microscopy, Electron, Scanning; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Swine; Vancomycin	2012
Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:10 Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin	2012
Necrotizing pneumonia in the community. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:17 Topics: Anti-Bacterial Agents; Fatal Outcome; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Necrosis; Pneumonia, Staphylococcal; Staphylococcal Infections; Treatment Failure; Vancomycin	2012
Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody. Pharmacotherapy, 2012, Volume: 32, Issue:11 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Daptomycin; Diagnosis, Differential; Doxycycline; Drug Monitoring; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Purpura, Thrombocytopenic, Idiopathic; Recurrence; Staphylococcal Infections; Thrombocytopenia; Vancomycin	2012
Community-associated methicillin-resistant Staphylococcus aureus necrotizing pneumonia in a healthy neonate. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2014, Volume: 47, Issue:6 Topics: Anti-Bacterial Agents; Community-Acquired Infections; Empyema; Female; Humans; Infant, Newborn; Lung; Methicillin-Resistant Staphylococcus aureus; Necrosis; Pneumonectomy; Pneumonia, Staphylococcal; Respiratory Syncytial Virus Infections; Vancomycin	2014
Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population. American journal of surgery, 2013, Volume: 205, Issue:3 Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage; Female; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome; Vancomycin; Wounds, Nonpenetrating	2013
Vancomycin for Staphylococcus aureus therapy of respiratory tract infections: the end of an era? International journal of antimicrobial agents, 2003, Volume: 21, Issue:6 Topics: Anti-Bacterial Agents; Humans; Methicillin; Methicillin Resistance; Penicillins; Pneumonia, Staphylococcal; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	2003
[Vancomycin-induced linear IgA bullous dermatosis]. Presse medicale (Paris, France : 1983), 2003, Jun-28, Volume: 32, Issue:23 Topics: Aged; Anti-Bacterial Agents; Biopsy; Complement C3; Drug Eruptions; Epidermolysis Bullosa, Junctional; Humans; Immunoglobulin A; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Skin; Vancomycin	2003
STAPHYLOCOCCAL PNEUMONIA IN CHILDHOOD. GP, 1964, Volume: 29 Topics: Abscess; Anti-Bacterial Agents; Bacitracin; Bronchial Fistula; Chloramphenicol; Empyema; Erythromycin; Humans; Kanamycin; Novobiocin; Penicillins; Pleural Effusion; Pneumonia; Pneumonia, Staphylococcal; Pneumothorax; Sepsis; Staphylococcal Infections; Tetracycline; Vancomycin	1964
Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2003, Volume: 7, Issue:3 Topics: Anti-Bacterial Agents; Fatal Outcome; Humans; Infant; Male; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcus aureus; Treatment Failure; Vancomycin; Vancomycin Resistance	2003
Nosocomial pneumonia: therapy is just not good enough. Chest, 2003, Volume: 124, Issue:5 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Vancomycin	2003
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest, 2003, Volume: 124, Issue:5 Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Double-Blind Method; Female; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Regression Analysis; Vancomycin	2003
Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin. Critical care medicine, 2004, Volume: 32, Issue:1 Topics: Acetamides; Cohort Studies; Cost-Benefit Analysis; Drug Costs; Female; Hospital Costs; Humans; Intensive Care Units; Linezolid; Male; Oxazolidinones; Pneumonia, Aspiration; Pneumonia, Staphylococcal; Quality-Adjusted Life Years; Respiration, Artificial; Respiratory Distress Syndrome; United States; Vancomycin; Ventilators, Mechanical	2004
Linezolid in VAP by MRSA: a better choice? Intensive care medicine, 2004, Volume: 30, Issue:3 Topics: Acetamides; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Vancomycin	2004
Linezolid and vancomycin for methicillin-resistant Staphylococcus aureus nosocomial pneumonia: the subtleties of subgroup analyses. Chest, 2004, Volume: 126, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Vancomycin	2004
New recommendations for vancomycin dosage for patients with MRSA pneumonia with various degrees of renal function impairment. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:4 Topics: Aged; Aged, 80 and over; Female; Humans; Kidney Diseases; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2005
Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides. Critical care medicine, 2005, Volume: 33, Issue:9 Topics: Anti-Bacterial Agents; APACHE; Cohort Studies; Drug Resistance, Bacterial; Female; Glycopeptides; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Oxacillin; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Teicoplanin; Vancomycin; Ventilators, Mechanical	2005
MRSA pneumonia: better outcome through continuous infusion of vancomycin? Critical care medicine, 2005, Volume: 33, Issue:9 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Infusions, Intravenous; Intensive Care Units; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2005
Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2005, Volume: 9, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Drug Costs; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Respiration, Artificial; Staphylococcus aureus; Vancomycin	2005
A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia. Infection, 2006, Volume: 34, Issue:3 Topics: Acetamides; Aged; Anti-Bacterial Agents; Critical Illness; Cross Infection; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin	2006
[Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus]. Enfermedades infecciosas y microbiologia clinica, 2005, Volume: 23 Suppl 3 Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Prognosis; Respiration, Artificial; Staphylococcus aureus; Vancomycin; Virulence	2005
Potency of DX-619, a novel des-F(6)-quinolone, in haematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. International journal of antimicrobial agents, 2006, Volume: 28, Issue:3 Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Lung; Male; Methicillin; Methicillin Resistance; Mice; Pneumonia, Staphylococcal; Pyrrolidines; Quinolones; Specific Pathogen-Free Organisms; Staphylococcus aureus; Vancomycin	2006
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clinical therapeutics, 2006, Volume: 28, Issue:8 Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Female; Health Care Costs; Humans; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Staphylococcus aureus; Vancomycin	2006
Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen? Chest, 2006, Volume: 130, Issue:4 Topics: Anti-Bacterial Agents; Biological Availability; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin; Ventilators, Mechanical	2006
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest, 2006, Volume: 130, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Cohort Studies; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hospital Mortality; Humans; Male; Methicillin Resistance; Middle Aged; Missouri; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Staphylococcus aureus; Survival Analysis; Treatment Outcome; Vancomycin	2006
Methicillin-resistant Staphylococcus aureus necrotizing pneumonia arising from an infected episiotomy site. Obstetrics and gynecology, 2007, Volume: 109, Issue:2 Pt2 Topics: Adult; Anti-Bacterial Agents; Diagnosis, Differential; Episiotomy; Female; Humans; Infusions, Intravenous; Methicillin Resistance; Pneumonia, Staphylococcal; Pregnancy; Puerperal Disorders; Surgical Wound Infection; Tomography, X-Ray Computed; Vancomycin	2007
Economic evaluation of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2006, Volume: 10, Issue:4 Topics: Acetamides; Anti-Infective Agents; Cost-Benefit Analysis; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Staphylococcus aureus; Vancomycin	2006
What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus? Critical care medicine, 2007, Volume: 35, Issue:3 Topics: Anti-Bacterial Agents; Cost Control; Cross Infection; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Infusions, Intravenous; Intensive Care Units; Length of Stay; Methicillin Resistance; Pneumonia, Staphylococcal; Retrospective Studies; Staphylococcus aureus; Treatment Outcome; Vancomycin; Ventilators, Mechanical	2007
Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy. The Annals of thoracic surgery, 2007, Volume: 83, Issue:5 Topics: Acetamides; Aged; Aged, 80 and over; Anti-Infective Agents; Cross Infection; Female; Humans; Linezolid; Male; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Thoracic Surgical Procedures; Treatment Failure; Treatment Outcome; Vancomycin	2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Decision Support Techniques; Dose-Response Relationship, Drug; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Randomized Controlled Trials as Topic; Research Design; Retrospective Studies; Staphylococcus aureus; Survival Rate; Vancomycin	2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clinical therapeutics, 2007, Volume: 29, Issue:2 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Disclosure; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Peer Review, Research; Pneumonia, Staphylococcal; Research Design; Staphylococcus aureus; Vancomycin	2007
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clinical therapeutics, 2007, Volume: 29, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2007
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clinical therapeutics, 2007, Volume: 29, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cohort Studies; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Female; Humans; Kidney; Kidney Diseases; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Staphylococcus aureus; Vancomycin	2007
Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia. Chest, 2007, Volume: 132, Issue:3 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Research Design; Staphylococcus aureus; Vancomycin	2007
Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia. Chest, 2007, Volume: 132, Issue:3 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Treatment Outcome; Vancomycin	2007
Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics. Chest, 2007, Volume: 132, Issue:3 Topics: Anti-Bacterial Agents; Cross Infection; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2007
Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia. Pediatric pulmonology, 2008, Volume: 43, Issue:2 Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Community-Acquired Infections; Drug Administration Schedule; Gentamicins; Humans; Infant, Newborn; Methicillin Resistance; Necrosis; Pneumonia, Staphylococcal; Rifampin; Staphylococcus aureus; Twins; Vancomycin	2008
[A case of primary peritonitis and bilateral pneumonia caused by staphylococcal emboli in drug dependence]. Minerva chirurgica, 1984, Apr-15, Volume: 39, Issue:7 Topics: Adolescent; Female; Heroin Dependence; Humans; Injections, Intravenous; Peritonitis; Pneumonia, Staphylococcal; Rifampin; Staphylococcal Infections; Vancomycin	1984
[Use of vancomycin in the treatment of severe Staphylococcus aureus infection. Description of 3 cases]. Minerva medica, 1984, Feb-28, Volume: 75, Issue:8 Topics: Adolescent; Anti-Bacterial Agents; Child; Cross Infection; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Infant; Male; Pneumonia, Staphylococcal; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1984
[Vancomycin-induced thrombocytopenia for MRSA pneumonia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:8 Topics: Aged; Anti-Bacterial Agents; Humans; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Staphylococcus aureus; Thrombocytopenia; Vancomycin	1995
[Treatment of severe pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) and Candida krusei with granulocyte colony-stimulating factor (G-CSF): a case report]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1993, Volume: 67, Issue:8 Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Granulocyte Colony-Stimulating Factor; Humans; Lung Diseases, Fungal; Male; Methicillin Resistance; Miconazole; Pneumonia; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	1993
[Japanese-United States vancomycin forum (2). Discussion]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:2 Topics: Aged; Aged, 80 and over; Child, Preschool; Enteritis; Humans; Infant; Methicillin Resistance; Pneumonia, Staphylococcal; Pressure Ulcer; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1995
[Clinical analysis of MRSA pneumonia. Niigata Research Group of MRSA.ABK]. The Japanese journal of antibiotics, 1994, Volume: 47, Issue:6 Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Therapy, Combination; Female; Humans; Japan; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	1994
[Mechanism of vancomycin resistance in MRSA strain Mu50]. The Japanese journal of antibiotics, 1998, Volume: 51, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Carrier Proteins; Cell Wall; Drug Resistance, Microbial; Hexosyltransferases; Humans; Methicillin Resistance; Microscopy, Electron, Scanning Transmission; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan; Peptidyl Transferases; Pneumonia, Staphylococcal; Staphylococcus aureus; Surgical Wound Infection; Vancomycin	1998
Methicillin-resistant Staphylococcus intermedius pneumonia following coronary artery bypass grafting. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:1 Topics: Aged; Anti-Bacterial Agents; Coronary Artery Bypass; Humans; Male; Methicillin Resistance; Pneumonia, Staphylococcal; Postoperative Complications; Staphylococcus; Treatment Outcome; Vancomycin	1999
Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, Oct-15, Volume: 57 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Female; Humans; Male; Middle Aged; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	2000
A new type of penicillin resistance of Staphylococcus aureus. Lancet (London, England), 1977, Feb-26, Volume: 1, Issue:8009 Topics: Adult; Autolysis; Bacteriolysis; Cephalothin; Child, Preschool; Drug Tolerance; Endocarditis, Bacterial; Female; Humans; Infant; Male; Methicillin; Microbial Sensitivity Tests; Middle Aged; Nafcillin; Osteomyelitis; Penicillin Resistance; Penicillins; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1977
Postoperative complications due to methicillin-resistant Staphylococcus aureus (MRSA) in an elderly patient: management and control of MRSA. The Journal of hospital infection, 1992, Volume: 22 Suppl A Topics: Adenocarcinoma; Aged; Bacteremia; Colonic Neoplasms; Cross Infection; Disease Outbreaks; Female; Humans; Methicillin Resistance; Pneumonia, Staphylococcal; Postoperative Complications; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin	1992
What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin? Archives of surgery (Chicago, Ill. : 1960), 1989, Volume: 124, Issue:12 Topics: Burns; Humans; Methicillin; Penicillin Resistance; Pneumonia, Staphylococcal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin	1989
Comparison of the investigational drug, LY146032, with vancomycin in experimental pneumonia due to methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1988, Volume: 21, Issue:1 Topics: Animals; Anti-Bacterial Agents; Cricetinae; Daptomycin; Intubation, Intratracheal; Male; Mesocricetus; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Peptides; Pneumonia, Staphylococcal; Staphylococcus aureus; Vancomycin	1988